Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

133.21USD
19 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$133.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
203,718
52-wk High
$134.29
52-wk Low
$62.95

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or... (more)

Overall

Beta: 0.60
Market Cap (Mil.): $14,250.04
Shares Outstanding (Mil.): 106.97
Dividend: --
Yield (%): --

Financials

Search Stocks

Edwards CEO hopes FDA to accelerate approvals of medical devices

NEW YORK - U.S. health regulators appear open to speeding up approvals of medical devices that currently often reach European markets three to five years ahead of being cleared in the United States, the chief executive officer of Edwards Lifesciences said.

09 Dec 2014

UPDATE 1-Edwards Lifesciences Q3 net rises 23 pct, outlook increased

Oct 23 - Medical device maker Edwards Lifesciences Corp on Thursday said its quarterly net earnings rose 23 percent on strong sales of heart valves, prompting the company to raise its full-year earnings outlook and sending its shares up 7 percent.

24 Oct 2014

Edwards 3rd quarter net rises 23 pct, 2014 outlook increased

Oct 23 - Medical device maker Edwards Lifesciences Corp on Thursday said its quarterly net earnings rose 23 percent due to strong sales of heart valves, prompting the company to raise its full-year earnings outlook.

24 Oct 2014

Allergan CEO resigns from Edwards Lifesciences' board

Oct 3 - Edwards Lifesciences Corp said David Pyott resigned from the medical device maker's board to devote more time to his role as chairman and CEO of Allergan Inc .

04 Oct 2014

UPDATE 2-Legal settlement lifts Edwards Lifesciences' profit

July 29 - Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

30 Jul 2014

Edwards Lifesciences posts higher profit

July 29 - Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of its heart valves that are implanted in a less-invasive procedure than traditional open-heart surgery.

30 Jul 2014

Earnings vs. Estimates

Search Stocks